Literature DB >> 15248949

Spectrophotometric microdetermination of nefopam, mebevrine and phenylpropanolamine hydrochloride in pharmaceutical formulations using alizarins.

S A Shama1, A S Amin.   

Abstract

Simple and rapid spectrophotometric procedures have been established for quantitation of nefopam hydrochloride (NF) mebevrine hydrochloride (MB) and phenylpropanolamine hydrochloride (PP). The procedures are based on the reaction between the examined drugs (NF, MB and PP) and alizarin (I), alizarin red S (II), alizarin yellow G (III) and quinalizarin (IV) producing ion-pair complexes which can be measured at the optimum wavelength. The optimization of the reaction conditions is investigated. Beer's law is obeyed in the concentration ranges 0.5-30.0 microg ml(-1). The molar absorptivity, Sandell sensitivity, detection and quantification limits are also calculated. The correlation coefficient was > or =0.9988 (n=6) with a relative standard deviation (R.S.D.) of < or =1.3, for six determinations of 20 microg ml(-1). The methods are successfully applied to the determination of NF, MB and PP in their pharmaceutical formulations.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15248949     DOI: 10.1016/j.saa.2003.07.012

Source DB:  PubMed          Journal:  Spectrochim Acta A Mol Biomol Spectrosc        ISSN: 1386-1425            Impact factor:   4.098


  2 in total

1.  First derivative synchronous fluorescence spectroscopy for the simultaneous determination of sulpiride and mebeverine hydrochloride in their combined tablets and application to real human plasma.

Authors:  M Walash; M Sharaf El-Din; Nahed El-Enany; M Eid; Sh Shalan
Journal:  J Fluoresc       Date:  2010-07-07       Impact factor: 2.217

2.  A stability indicating HPLC method for determination of mebeverine in the presence of its degradation products and kinetic study of its degradation in oxidative condition.

Authors:  E Souri; A Negahban Aghdami; N Adib
Journal:  Res Pharm Sci       Date:  2014 May-Jun
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.